Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wanbury
Navi Mumbai, Maharashtra, India
- Ownership
- Private
- Development stage
- Other
01
Overview
Wanbury is the largest Indian manufacturer of metformin and a major exporter of Tramadol, with a portfolio of 13+ APIs and around 70 branded formulations; the company's facilities are USFDA, EU GMP, and KFDA certified, and it distributes globally with a strong regulatory compliance record[1][2][3][4].
- Therapeutic areas
- ImmunologyEndocrinologyPsychiatryGastroenterologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Top five global generic players (supplier relationship stated, but not named)
Beyond the preview
Go deeper on Wanbury.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wanbury.